JP6530056B2 - 骨選択的骨形成オキシステロールビスホスホネート類似体 - Google Patents

骨選択的骨形成オキシステロールビスホスホネート類似体 Download PDF

Info

Publication number
JP6530056B2
JP6530056B2 JP2017510457A JP2017510457A JP6530056B2 JP 6530056 B2 JP6530056 B2 JP 6530056B2 JP 2017510457 A JP2017510457 A JP 2017510457A JP 2017510457 A JP2017510457 A JP 2017510457A JP 6530056 B2 JP6530056 B2 JP 6530056B2
Authority
JP
Japan
Prior art keywords
bone
oxy133
compound
aln
mol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2017510457A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017514910A (ja
JP2017514910A5 (US07981874-20110719-C00313.png
Inventor
パルハミ，ファルハド
スタッペンベック，フランク
チェンバレン，ブライアン・ティー
Original Assignee
ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・カリフオルニア
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・カリフオルニア filed Critical ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・カリフオルニア
Publication of JP2017514910A publication Critical patent/JP2017514910A/ja
Publication of JP2017514910A5 publication Critical patent/JP2017514910A5/ja
Application granted granted Critical
Publication of JP6530056B2 publication Critical patent/JP6530056B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0055—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of at least three carbon atoms which may or may not be branched, e.g. cholane or cholestane derivatives, optionally cyclised, e.g. 17-beta-phenyl or 17-beta-furyl derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP2017510457A 2014-05-02 2015-05-01 骨選択的骨形成オキシステロールビスホスホネート類似体 Expired - Fee Related JP6530056B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461987739P 2014-05-02 2014-05-02
US61/987,739 2014-05-02
PCT/US2015/028917 WO2015168636A1 (en) 2014-05-02 2015-05-01 Bone-selective osteogenic oxysterol bisphosphonate analogs

Publications (3)

Publication Number Publication Date
JP2017514910A JP2017514910A (ja) 2017-06-08
JP2017514910A5 JP2017514910A5 (US07981874-20110719-C00313.png) 2018-06-14
JP6530056B2 true JP6530056B2 (ja) 2019-06-12

Family

ID=54359404

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017510457A Expired - Fee Related JP6530056B2 (ja) 2014-05-02 2015-05-01 骨選択的骨形成オキシステロールビスホスホネート類似体

Country Status (7)

Country Link
US (1) US10421773B2 (US07981874-20110719-C00313.png)
EP (1) EP3137480A4 (US07981874-20110719-C00313.png)
JP (1) JP6530056B2 (US07981874-20110719-C00313.png)
CN (1) CN106232612B (US07981874-20110719-C00313.png)
AU (1) AU2015252859B2 (US07981874-20110719-C00313.png)
CA (1) CA2945404A1 (US07981874-20110719-C00313.png)
WO (1) WO2015168636A1 (US07981874-20110719-C00313.png)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1993558B1 (en) 2006-02-27 2014-07-30 The Regents of The University of California Oxysterol compounds and the hedgehog pathway
US9717742B2 (en) 2012-05-07 2017-08-01 The Regents Of The University Of California Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis
US9683009B2 (en) 2013-05-02 2017-06-20 The Regents Of The University Of California Bone-selective osteogenic oxysterol-bone targeting agents
WO2016094421A1 (en) 2014-12-09 2016-06-16 Warsaw Orthopedic, Inc. Compounds and methods involving sterols
US9877836B2 (en) 2015-07-10 2018-01-30 Warsaw Orthopedic, Inc. Compression resistant implants including an oxysterol and methods of use
US10632230B2 (en) 2015-07-10 2020-04-28 Warsaw Orthopedic, Inc. Implants having a high drug load of an oxysterol and methods of use
US9987289B2 (en) 2015-07-10 2018-06-05 Warsaw Orthopedic, Inc. Slow release oxysterols and methods of use
US9637514B1 (en) 2015-10-26 2017-05-02 MAX BioPharma, Inc. Oxysterols and hedgehog signaling
US20170275330A1 (en) * 2016-03-28 2017-09-28 Warsaw Orthopedic, Inc. Polymorphic forms of an oxysterol and methods of making them
US10688222B2 (en) 2016-11-21 2020-06-23 Warsaw Orthopedic, Inc. Lyophilized moldable implants containing an oxysterol
US11384114B2 (en) 2016-12-09 2022-07-12 Warsaw Orthopedic, Inc. Polymorphic forms of an oxysterol and methods of making them
US10294264B2 (en) * 2017-04-21 2019-05-21 Warsaw Orthopedic, Inc. Oxysterol-therapeutic agent derivative for bone healing
US10434106B2 (en) * 2017-05-19 2019-10-08 Warsaw Orthopedic, Inc. Oxysterol-statin compounds for bone growth
US11464888B2 (en) 2017-06-12 2022-10-11 Warsaw Orthopedic, Inc. Moldable formulations containing an oxysterol in an acellular tissue matrix
EP3827010A4 (en) * 2018-07-23 2022-03-16 Brise Pharmaceuticals Co., Ltd. BISPHOSPHONATE-DRUG CONJUGATES

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
EP0496520A1 (en) 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体
JPH06329697A (ja) * 1993-03-25 1994-11-29 Kowa Co 骨疾患治療剤
DE102004032781A1 (de) 2004-01-23 2005-08-11 Mcs Micro Carrier Systems Gmbh Bisphosphonsäurederivate
EP1993558B1 (en) * 2006-02-27 2014-07-30 The Regents of The University of California Oxysterol compounds and the hedgehog pathway
US8071575B2 (en) * 2007-02-23 2011-12-06 University Of Louisville Research Foundation Methods and compounds for the targeted delivery of agents to bone for interaction therewith
CA2707663C (en) * 2007-12-03 2017-05-30 The Regents Of The University Of California Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling
WO2012024584A2 (en) * 2010-08-20 2012-02-23 Fate Therapeutics, Inc. Oxysterol compounds
WO2013169397A1 (en) * 2012-05-07 2013-11-14 The Regents Of The University Of California Novel oxysterol analogue, oxy149, induces osteogenesis and hedgehog signaling and inhibits adipogenesis
US9717742B2 (en) * 2012-05-07 2017-08-01 The Regents Of The University Of California Oxysterol analogue OXY133 induces osteogenesis and hedgehog signaling and inhibits adipogenesis

Also Published As

Publication number Publication date
JP2017514910A (ja) 2017-06-08
US10421773B2 (en) 2019-09-24
AU2015252859A1 (en) 2016-10-20
WO2015168636A1 (en) 2015-11-05
CA2945404A1 (en) 2015-11-05
EP3137480A1 (en) 2017-03-08
CN106232612B (zh) 2019-01-29
CN106232612A (zh) 2016-12-14
AU2015252859B2 (en) 2019-11-07
EP3137480A4 (en) 2017-11-29
US20170022244A1 (en) 2017-01-26

Similar Documents

Publication Publication Date Title
JP6530056B2 (ja) 骨選択的骨形成オキシステロールビスホスホネート類似体
TWI717026B (zh) 使用齊墩果酸(bardoxolone methyl)或其類似物治療和預防內皮功能障礙之方法
EP3307262B1 (en) Compounds for use in treating neuromuscular disorders
AU2014259672A1 (en) Bone-selective osteogenic oxysterol-bone targeting agents
JP2022028904A (ja) シリコン系薬物複合体及びその使用方法
ES2197232T3 (es) Compuestos que contienen benzopirano y procedimiento de uso.
KR100858464B1 (ko) 콤브레타스타틴 ａ-4 인산염 프로드럭 모노- 및 디-유기아민 염, 모노- 및 디-아미노산 염, 그리고 모노- 및디-아미노산 에스테르 염
US20170056510A1 (en) Targeted therapeutics
TWI780380B (zh) 含有肝靶向特異性配體和甲狀腺素受體激動劑的藥物、用途和藥物組合物
AU2017200927A1 (en) Methods for inhibiting muscle atrophy
WO2018096504A1 (en) Cbd prodrugs, compositions, and methods of administering cbd and cbd prodrugs
US20220267780A1 (en) Conjugates of bile acids and their derivatives for active molecules delivery
PT1776377E (pt) Novo agonista esteróide dos fxr
CA2882417A1 (en) C17-heteroaryl derivatives of oleanolic acid and methods of use thereof
Pal et al. Discovery of orally bioavailable and brain-penetrable prodrugs of the potent nSMase2 inhibitor DPTIP
CA3121410C (en) Drug containing liver targeting specific ligand and thyroid hormone receptor agonist
WO2005005433A1 (ja) 高カルシウム血症および骨疾患治療剤
JP2023514951A (ja) 脂質化合物及びその組成物
CA3107823A1 (en) Methods of activating microglial cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180501

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20181206

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190108

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190404

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190416

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190515

R150 Certificate of patent or registration of utility model

Ref document number: 6530056

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees